Page 7 - Read Online
P. 7

Santoni et al. J Cancer Metastasis Treat 2020;6:22  I  http://dx.doi.org/10.20517/2394-4722.2020.49                      Page 3 of 14






























               Figure 1. Dual role of p21 Cip1  pathway in cancer

               pathway via over-expression of β1-integrin receptors, and engagement of the transcription factor Sp1 and
                                                              Cip1
               the P300 co-activator p21 Cip1[15] . Down-regulation of p21  mRNA expression can also be induced by c-Myc
                                                                                        [16]
               through interactions with the initiator binding zinc finger transcription factor, MIZ-1 . Similarly, the pro-
                                                  Cip1
                                                                                     Cip1
               myelotic zinc finger can bind to the p21  promoter, thus blocking the Sp1/p21  promoter interaction
                              Cip1
                                          [17]
               and reducing p21  expression . The liver kinase B1 is a serine/threonine kinase that activates AMPK and
                                                                                                        Cip1
               regulates cell growth and apoptosis by triggering a p53-dependent p21  increase [18,19] . Enhanced p21
                                                                             Cip1
               levels, induced by increased p53 and Sp1/DNA binding activity, have been also found in human fibroblasts
               during replicative senescence [20-22] . Moreover, the alkylating agent Temozolomide (TMZ) induces G2-M cell
               cycle arrest and senescence through the Mre11-Rad50-Nbs1 (MRN) complex and activation of the ATR/
               CHK1 axis. TMZ-induced senescence requires a functional p53, a functional NF-κB pathway, as well as a
               sustained p21Cip1 induction. Upon TMZ exposure, as a consequence of the E2F1/DP1 complex disruption,
                                                                                                   [23]
               a strong repression of the mismatch repair proteins MSH2, MSH6, EXO1 and RAD51 was observed .
               The Wnt signaling pathway is a critical regulator of cancer stem cell (CSC) features and has been associated
                                                                                                 +
                                                                                           +
               with poor prognosis. Its downregulation is responsible for diminished numbers of CD133 CD44  CSCs [in
               this regard, recent studies on colon cancer have demonstrated that the knock-down of zeste homologue 2
               (EZH2), a key component of the Polycomb-Repressive Complex 2, is involved in maintaining the
               transcriptional repressive state of cycle arrest and apoptosis of CSC-like cells . EZH2 expression positively
                                                                                [24]
               correlates with levels of Wnt/β-catenin pathway target genes. EZH2 is essential for the maintenance of
                                              [25]
               CSC-like cell properties] [Figure 2] . Several findings demonstrate that EZH2 knockdown inactivates
                                                        Cip1
                                                                                                 [25]
               the Wnt/β-catenin pathway by increasing p21  expression, resulting in G1/S-phase arrest . EZH2
               knockdown in CD133 /CD44  SW480 cells has been shown to induce the increase of p21  Cip1  with
                                          +
                                    +
               consequent reduction of β-catenin, vimentin and c-Myc expression. Moreover, the inhibition of EZH2 via
               a specific inhibitor promotes enhancement of p21  expression and inactivation of the Wnt/β-catenin
                                                           Cip1
                      [25]
               pathway .
               Interestingly, the role of EZH2 in chemotherapy drug resistance has also been investigated. A decrease in
               EZH2 expression was demonstrated to promote apoptosis, cell cycle arrest at the G1/S phase, and reduce
                                                                             [26]
               expression of multi-drug resistant proteins in TMZ-resistant GBM cells . GSC maintenance involves the
               cell-division cycle protein 20 (CDC20), an activator of the E3 ubiquitination ligase complex. Silencing
   2   3   4   5   6   7   8   9   10   11   12